U.S. Markets closed

Takeda Pharmaceutical Company Limited (TKPYY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
27.15+0.32 (+1.19%)
At close: 3:59PM EDT
People also watch
ALPMYESALYDSNKYTKPHFSVNDY
Full screen
Previous Close26.83
Open27.09
Bid0.00 x 0
Ask0.00 x 0
Day's Range27.04 - 27.29
52 Week Range19.96 - 27.35
Volume129,849
Avg. Volume59,376
Market Cap41.98B
Beta0.41
PE Ratio (TTM)41.58
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.78 (2.93%)
Ex-Dividend Date2016-09-28
1y Target EstN/A
Trade prices are not sourced from all markets
  • Market Realist9 days ago

    How Celgene’s Pomalyst Is Positioned after 2Q17

    In 2Q17, Celgene’s (CELG) Pomalyst generated revenues of ~$391 million, which reflected ~23% growth on a year-over-year basis.

  • Capital Cube15 days ago

    ETFs with exposure to Takeda Pharmaceutical Co., Ltd. : August 4, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Takeda Pharmaceutical Co., Ltd. Here are 5 ETFs with the largest exposure to TKPYY-US. Comparing the performance and risk of Takeda Pharmaceutical Co., Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Seattle Genetics (SGEN) Q2 Loss Narrower than Expected
    Zacks22 days ago

    Seattle Genetics (SGEN) Q2 Loss Narrower than Expected

    Seattle Genetics (SGEN) incurred narrower-than-expected loss in Q2 and provided an encouraging guidance for Adcetris.